DE69917717D1 - C11-Carbamate von antibakteriellen Makroliden - Google Patents

C11-Carbamate von antibakteriellen Makroliden

Info

Publication number
DE69917717D1
DE69917717D1 DE69917717T DE69917717T DE69917717D1 DE 69917717 D1 DE69917717 D1 DE 69917717D1 DE 69917717 T DE69917717 T DE 69917717T DE 69917717 T DE69917717 T DE 69917717T DE 69917717 D1 DE69917717 D1 DE 69917717D1
Authority
DE
Germany
Prior art keywords
compounds
formula
relates
carbamates
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69917717T
Other languages
English (en)
Other versions
DE69917717T2 (de
Inventor
Hengmiao Cheng
Michael Anthony Letavic
Carl Bernard Ziegler
Jason Kenneth Dutra
Peter Bertinato
Brian Scott Bronk
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Products Inc
Original Assignee
Pfizer Products Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc filed Critical Pfizer Products Inc
Publication of DE69917717D1 publication Critical patent/DE69917717D1/de
Application granted granted Critical
Publication of DE69917717T2 publication Critical patent/DE69917717T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
DE69917717T 1998-08-19 1999-07-29 C11-Carbamate von antibakteriellen Makroliden Expired - Fee Related DE69917717T2 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US9707598P 1998-08-19 1998-08-19
US97075P 1998-08-19
US10478598P 1998-10-19 1998-10-19
US104785P 1998-10-19

Publications (2)

Publication Number Publication Date
DE69917717D1 true DE69917717D1 (de) 2004-07-08
DE69917717T2 DE69917717T2 (de) 2004-09-23

Family

ID=26792507

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69917717T Expired - Fee Related DE69917717T2 (de) 1998-08-19 1999-07-29 C11-Carbamate von antibakteriellen Makroliden

Country Status (10)

Country Link
US (1) US6043227A (de)
EP (1) EP0984019B1 (de)
JP (1) JP2000063397A (de)
AT (1) ATE268337T1 (de)
BR (1) BR9903737A (de)
CA (1) CA2280328C (de)
DE (1) DE69917717T2 (de)
DK (1) DK0984019T3 (de)
ES (1) ES2220008T3 (de)
PT (1) PT984019E (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6710033B1 (en) 1996-08-14 2004-03-23 Vanderbilt University Methods and treatment of multiple sclerosis
US6890526B2 (en) 1997-05-06 2005-05-10 Vanderbilt University Methods and reagents for the treatment of multiple sclerosis
AP9801420A0 (en) * 1998-01-02 1998-12-31 Pfizer Prod Inc Novel macrolides.
AP1060A (en) * 1998-01-02 2002-04-23 Pfizer Prod Inc Novel erythromycin derivatives.
CA2411293A1 (en) * 1999-01-28 2000-07-28 Pfizer Products Inc. Novel azalides and methods of making same
AP2001002302A0 (en) * 1999-05-24 2001-10-25 Pfizer Prod Inc 13-Methyl erythromycin derivatives.
EP1101769A3 (de) * 1999-11-18 2001-10-24 Pfizer Products Inc. Stickstoff-enthaltend Erythromycin-Derivate
AU2001247629A1 (en) * 2000-03-22 2001-10-03 Thomas Jefferson University Use of azithromycin for infections with leishmania
AU2003215245A1 (en) * 2002-02-15 2003-09-09 Sympore Gmbh Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
US7579324B2 (en) 2002-02-15 2009-08-25 C-A-I-R Biosciences Gmbh Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
AU2003211113B2 (en) * 2002-02-15 2007-08-09 Merckle Gmbh Antibiotic conjugates
US20040186063A1 (en) * 2002-02-15 2004-09-23 Hans-Jurgen Gutke Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
RS20050008A (en) 2002-07-08 2007-06-04 Pliva-Istraživački Institut D.O.O., New compounds,compositions and methods for treatment of inflammatory diseases and conditions
JP4530851B2 (ja) 2002-07-08 2010-08-25 グラクソスミスクライン・イストラジヴァッキ・センタル・ザグレブ・ドルズバ・ゼー・オメイェノ・オドゴヴォルノスティオ ステロイド／非ステロイド抗炎症活性分子、抗新生物活性分子および抗ウイルス活性分子用担体としての新規な化合物、組成物
PL374646A1 (en) 2002-07-08 2005-10-31 Pliva-Istrazivacki Institutt D.O.O. Novel nonsteroidal anti-inflammatory substances, compositions and methods for their use
JP2009502838A (ja) * 2005-07-26 2009-01-29 メルクレ，ゲーエムベーハー ピロリジンおよびインドリジン化合物のマクロライド接合体
CN101423539B (zh) * 2008-12-09 2011-04-27 山东大学 4″,11-二氨基甲酸酯阿奇霉素衍生物、制备方法及其药物组合物
FR2995605B1 (fr) * 2012-09-18 2014-09-19 Sanofi Sa Derives de macrolides, leur preparation et leur application therapeutique.
CN104844671B (zh) * 2015-05-19 2017-07-04 山东大学 11‑o‑芳烷基氨基甲酸酯克拉霉素衍生物及其制备方法与应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI8110592A8 (en) * 1981-03-06 1996-06-30 Pliva Pharm & Chem Works Process for preparing of n-methyl-11-aza-10-deoxo-10-dihydroerythromycine a and derivatives thereof
PH19293A (en) * 1982-11-15 1986-03-04 Pfizer Epimeric azahomoerythromycin,pharmaceutical composition containing the same and method of use thereof
US4464527A (en) * 1983-06-30 1984-08-07 Pfizer Inc. Antibacterial 9-deoxo-9a-alkyl-9a-aza-9a-homoerythromycin A derivatives and intermediates therefore
KR880009960A (ko) * 1987-02-24 1988-10-06 데이빗 로버츠 화학적 화합물
KR930702369A (ko) * 1990-10-15 1993-09-08 우에노 아키라 에리쓰로마이신 또는 그의 유도체의 2'위치 수식 화합물
CA2064634C (en) * 1991-04-04 1998-08-04 James V. Heck 9-deoxo-8a-aza-8a-homoerythromycin a derivatives modified at the 4"- and8a-positions
HRP930014A2 (en) * 1993-01-08 1994-08-31 Pliva Pharm & Chem Works 9-deoxo-9a-aza-11-deoxy-9a-homoeritromycin a 9a, 11-cyclic carbamates
HN1998000086A (es) * 1997-06-11 1999-03-08 Pfizer Prod Inc Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos.
HN1998000074A (es) * 1997-06-11 1999-01-08 Pfizer Prod Inc Derivados de macrolidos c-4 sustituidos
HRP970714B1 (en) * 1997-12-31 2003-08-31 Pliva Pharm & Chem Works Beta,beta-disubstituted derivatives of 9-deoxo-9a-n-ethenyl-9a-aza-9a-homoerythromycin a
AP9801420A0 (en) * 1998-01-02 1998-12-31 Pfizer Prod Inc Novel macrolides.

Also Published As

Publication number Publication date
CA2280328A1 (en) 2000-02-19
EP0984019B1 (de) 2004-06-02
EP0984019A1 (de) 2000-03-08
DE69917717T2 (de) 2004-09-23
JP2000063397A (ja) 2000-02-29
ATE268337T1 (de) 2004-06-15
BR9903737A (pt) 2000-09-19
CA2280328C (en) 2005-07-26
ES2220008T3 (es) 2004-12-01
PT984019E (pt) 2004-08-31
US6043227A (en) 2000-03-28
DK0984019T3 (da) 2004-08-30

Similar Documents

Publication Publication Date Title
EA199901014A1 (ru) C-4"-замещенные макролидные производные
DE69917717D1 (de) C11-Carbamate von antibakteriellen Makroliden
MY123354A (en) 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives
CY1111693T1 (el) Αντιιικοι παραγοντες
DE69716810D1 (de) 2,3-Disubstituierte-(5,6)-heteroarylkondensierte-pyrimidin-4-one
PA8486401A1 (es) Antibioticos cetolidos carbamato y carbazato
MY122353A (en) 13-membered azalides and their use as antibiotic agents
ATE277062T1 (de) Neue makrolidderivate
DE60102171D1 (de) Ketolidantibiotika
PT1167376E (pt) Antibioticos macrolidos
PT952157E (pt) Derivados 9a, 11b-desidro de 9-oxima-3-ceto-6-o-metileritromicina
DE69810332D1 (de) Antibakterielle carbapeneme, zusammensetzungen und verfahren zur behandlung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee